Xentuzumab

Tax included
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a humanized monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation.
MedChemExpress 
HY-P99274

Data sheet

Size
Multiple sizes
Reactivity
IGF-1R
Application
Cancer-Kinase/protease
CAS
1417158-65-6